PORTLAND, Maine--(BUSINESS WIRE)--
Employee-led Philanthropic Initiative Supports the Development and Training of Service Dogs that Help People with Disabilities Increase Independence
Covetrus (CVET), a global animal-health technology and services company supporting the companion, equine, and large-animal veterinary markets, today announced that its multi-year support of Canine Companions for Independence® has reached a momentous milestone with the delivery of its 2,000th Puppy Care Package.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190604005202/en/
Since 2015, Covetrus employees have supported Canine Companions for Independence, a non-profit organization that enhances the lives of people with disabilities by providing highly trained assistance dogs at no charge to the recipient. These past four years, Covetrus in partnership with veterinarians has provided Canine Companions volunteer puppy raisers with a Puppy Care Package stocked with products essential to raising the puppy during the first 18 months of life.
“We are thrilled to have delivered our 2,000th Puppy Care Package in support of Canine Companions for Independence,” said Davey Stone, vice president, specialty markets and corporate philanthropy, Covetrus. “This philanthropic initiative was designed and managed by Covetrus employees wanting to support volunteers who raise puppies for Canine Companions and the veterinarians who provide their care. It has been a rewarding mission for our employees, and a wonderful channel for their compassionate philanthropic spirit.”
The 2,000th box was delivered to Dr. Lee Kaplow of Lakeside Pet Hospital in Folsom, CA, which in turn granted it to volunteer puppy raiser Kim Brewer who is raising Fig, a Labrador Retriever. A Puppy Care Package includes $350.00 worth of products sourced from Covetrus and animal health manufacturers like Boehringer-Ingelheim, Kong Veterinary Products, Midmark Corporation, Nutramax and Virbac Animal Health.” Covetrus employees have supported this mission through consistent fundraising and in turn, the company has matched employee contributions and provided items for the boxes at a savings. In addition, employees take care of all the logistics associated with the Puppy Care Package—from the packing to the shipment—of these boxes to veterinarians.
“We’re grateful to Covetrus and their partners for providing the puppy care packages,” said Brenda Kennedy, national director of canine health and research at Canine Companions. “Our volunteer puppy raisers use the donated preventatives, supplements and supplies to ensure that each Canine Companion puppy gets a healthy start on their journey to becoming an assistance dog.”
Puppy raisers are responsible for socializing and training the puppies. The first 18 months is critical to training of future assistance dogs. In that time-span the puppy must learn 25 commands that enable them to assist their future partners, including opening doors, retrieving items, or pulling a wheelchair. After 18 months the puppies progress on to professional training for an additional four to six months. Upon graduation they are reunited with their puppy raiser and presented to their life-long partner.
Covetrus is a global animal-health technology and services company dedicated to empowering veterinary practice partners to drive improved health and financial outcomes. We’re bringing together products, services, and technology into a single platform that connects our customers to the solutions and insights they need to work best. Our passion for the well-being of animals and those who care for them drives us to advance the world of veterinary medicine. Covetrus is headquartered in Portland, Maine, with more than 5,000 employees, serving over 100,000 customers around the globe. For more information about Covetrus visit https://www.covetrus.com/.
This press release contains certain statements that are forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and that involve risks and uncertainties, including statements about our future financial and operating results, plans, objectives, expenses, expectations, intentions, trends in our business, our liquidity, product development and improvements, and other matters. We may, in some cases use terms such as “predicts,” “believes,” “potential,” “continue,” “anticipates,” “estimates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “likely,” “will,” “should” or other words that convey uncertainty of the future events or outcomes to identify these forward-looking statements. Such statements are subject to numerous risks and uncertainties, including but not limited to, risks associated with the ability to successfully integrate operations and employees; the ability to realize anticipated benefits and synergies of the transaction that created Covetrus; the potential impact of the consummation of the transaction on relationships, including with employees, customers and competitors; the ability to retain key personnel; the ability to achieve performance targets; changes in financial markets, interest rates and foreign currency exchange rates, and those additional risks and factors discussed in our Annual Report on Form 10-K filed on March 29, 2019 and Quarterly Report on Form 10-Q filed for the quarter ended March 31, 2019, including those discussed under the heading “Risk Factors.” Our forward-looking statements are based on current beliefs and expectations of our management team and, except as required by law, we undertake no obligations to make any revisions to the forward-looking statements contained in this release or to update them to reflect events or circumstances occurring after the date of this release, whether as a result of new information, future developments or otherwise. Investors are cautioned not to place undue reliance on these forward-looking statements.